Scott Jones

Senior Vice President & Chief Scientific Officer • BioBridge Global

Dr. Jones received his undergraduate degree in Microbiology from Texas A&M University and a Doctorate in Microbiology from The University of Texas Health Science Center at San Antonio. He did his Post Doctorate work at The Texas Center for Infectious Disease where he was the Director of the TB-RFLP Laboratory. Dr. Jones’ expertise includes blood screening testing, cell and gene therapy testing and analytical assay development and he has developed NAT assays for HIV-1, HCV, Parvo-B19, HAV and HEV. Since joining BioBridge Global in 1999, Dr. Jones has been instrumental in the organization’s expansion of R&D capabilities and strategic thought leadership in regenerative medicine. He has authored and presented numerous oral and poster presentations at the South Central Association of Blood Banks (SCABB), American Association of Blood Banks (AABB) and the Congress of International Society of Blood Transfusion annual meetings and serves as an active member of SCABB and AABB

Also Speaking

Mark Sawicki

President & Chief Executive Officer • Cryoport Systems

Carl H. June

Director of the Center for Cellular Immunotherapies at the Perelman School of Medicine • University of Pennsylvania

Will Rohleder

Development Director • Reef Group

Also Speaking


Post-Event Report

Download the post-event report for Advanced Therapies Week 2023.

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.